OpenNashPodcasts

Topic

PCSK9

7 facts from 4 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.

Undated

Daphne Koller cites PCSK9 as a target discovered through rare familial cholesterol variants whose drugs also help patients without those variants.

“A great example of that is the poster child here, which is PCSK9, where it was discovered in a rare familial variant in hypercholesterolemia on the one hand, familial hypercholesterolemia, familial hypocholesterolemia on the other, sort of showing this beautiful dose response.”

Daphne Koller · Ep79: Daphne Koller on Machine Learning for Drug Discovery, 1:01:42

Episodes